[Second-look operation or second-look laparoscopy for evaluating complete remission of ovarian cancer].
Doubtlessly the exploration of the peritoneal cavity is essential for the determination of the efficacy of cis platine chemotherapy in ovarian cancer. Second-look operation and second-look laparoscopy are established as diagnostic methods. In a follow up study containing 92 patients with CR after cis platine chemotherapy it has been evident that the remission time is independent on the kind of invasive diagnostic methods. In contrast to these results the noninvasive diagnostic methods (like CT or X ray in 19 pat.) survival time was 20 months. The difference to both other groups is significant. Therefore it is necessary in cases with complete response to secure the results invasively, but a second-look operation is not compulsary.
Krafft
W
W
Arbeitsgruppe Tumorchemotherapie in der Gynäkologie der DDR.
König
E M
EM
Schirmer
A
A
Müller
U
U
D000328:Adult; D002945:Cisplatin / Q000008:administration & dosage*; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D010535:Laparoscopy; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000601:surgery*; D010166:Palliative Care; D012086:Reoperation; D015996:Survival Rate
D002945:Cisplatin
Second-look Operation oder Second-look Laparoskopie zur Sicherung der kompletten Remission beim Ovarialkarzinom.